Lowenstein Sandler represented Catalyst Investors on the transaction. Tava Health, Inc., a provider of virtual mental health and telehealth services to therapists and employee assistance programs,...
Tava Health’s $20 Million Series B Funding Round
First Wave BioPharma’s Acquisition of ImmunogenX
Lowenstein represented First Wave BioPharma, Inc. in the transaction. First Wave BioPharma, Inc. (NASDAQ: FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic...
R.R. Donnelley & Sons’ Acquisition of Digital Print and Marketing Businesses from Vericast
Latham & Watkins LLP represented RRD, Lowenstein Sandler represented Chatham Asset Management, LLC, the sole owner of RRD, Kirkland & Ellis advised Vericast Corp. on the...
DarioHealth’s Acquisition of Twill
Lowenstein Sandler represented Twill, Inc. in the transaction. DarioHealth Corp. (NASDAQ: DRIO) executed the acquisition of Twill, Inc., a leader in digital-led care. The combination enables Dario...
Ezra’s $21 Million Fund Raise
Lowenstein represented Ezra in the transaction. Ezra, the healthcare artificial intelligence (AI) company transforming MRI imaging and early cancer detection, closed a $21 million fund raise that...
Architect Financial Technologies’ $12 Million Investment Round
Lowenstein Sandler represented BlockTower Capital and Tioga Capital Partners as co-lead investors in the round. Architect Financial Technologies, a Chicago, IL-based derivatives brokerage services and trading...
Shepherd’s $13.5 Million Series A Financing Round
Lowenstein Sandler represented Costanoa Ventures in the transaction. Shepherd, a San Francisco, CA-based provider of an insurance tech platform for commercial construction, closed the $13.5 million Series...
Goodshuffle Software’s $5 Million Series A Funding Round
Lowenstein Sandler represented FINTOP Capital in the transaction. Goodshuffle, a software company focused on the event rental and production industry, closed a $5 million Series A funding...
Colossyan’s $22 Million Series A Funding Round
Lowenstein Sandler represented Lakestar in the transaction. Colossyan, a London-based AI-text-to-video platform, closed its $22 million Series A funding round. The round saw participation from Lakestar,...
Timber Pharmaceuticals’ Chapter 11 and Asset Sale to Leo Pharma
Lowenstein Sandler represented Timber Pharmaceuticals, Inc. in the transaction. Timber Pharmaceuticals, Inc. (NYSE: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for...
Corbus Pharmaceuticals’ $94.5 Million Shares Public Offering
Lowenstein Sandler represented Corbus Pharmaceuticals Holdings, Inc. in the transaction. Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a precision oncology company with a diversified portfolio, announced the...
CIVC Partners’ Acquisition of Datavail Corp.
Kirkland & Ellis LLP served as legal counsel to CIVC, while Lowenstein Sandler LLP served as legal counsel to Catalyst Investors and Datavail on the transaction....